X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2063) 2063
Publication (278) 278
Newsletter (94) 94
Newspaper Article (22) 22
Book Review (14) 14
Book Chapter (9) 9
Magazine Article (6) 6
Conference Proceeding (3) 3
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1234) 1234
aztreonam (959) 959
female (569) 569
male (542) 542
aztreonam - pharmacology (499) 499
aztreonam - therapeutic use (491) 491
microbial sensitivity tests (446) 446
microbiology (437) 437
pharmacology & pharmacy (428) 428
anti-bacterial agents - pharmacology (425) 425
adult (416) 416
index medicus (413) 413
middle aged (353) 353
aged (298) 298
antibiotics (296) 296
anti-bacterial agents - therapeutic use (268) 268
aztreonam - administration & dosage (267) 267
bacterial infections - drug therapy (265) 265
infectious diseases (262) 262
pseudomonas aeruginosa - drug effects (221) 221
cystic fibrosis (201) 201
adolescent (198) 198
ceftazidime (177) 177
animals (173) 173
drug resistance, microbial (165) 165
infections (160) 160
research article (160) 160
bacteria (158) 158
anti-bacterial agents - administration & dosage (155) 155
pseudomonas aeruginosa (155) 155
aztreonam - adverse effects (154) 154
beta-lactamases - metabolism (153) 153
pseudomonas infections - drug therapy (149) 149
ceftazidime - pharmacology (140) 140
cephalosporins - pharmacology (132) 132
child (129) 129
gram-negative bacteria - drug effects (129) 129
aztreonam - pharmacokinetics (128) 128
resistance (125) 125
biochemical phenomena, metabolism, and nutrition (123) 123
kinetics (119) 119
bacteria - drug effects (114) 114
drug evaluation (114) 114
escherichia coli - drug effects (114) 114
gram-negative bacteria (114) 114
enterobacteriaceae - drug effects (113) 113
imipenem (113) 113
drug therapy, combination (111) 111
aztreonam - metabolism (108) 108
beta-lactamases - genetics (108) 108
cephalosporins (107) 107
pseudomonas-aeruginosa (107) 107
polycyclic compounds (104) 104
treatment outcome (104) 104
research (102) 102
urinary tract infections - drug therapy (100) 100
clinical trials as topic (98) 98
health aspects (97) 97
aged, 80 and over (96) 96
anti-bacterial agents - adverse effects (96) 96
escherichia-coli (96) 96
enterobacteriaceae (94) 94
drug resistance (89) 89
respiratory system (89) 89
cystic fibrosis - complications (88) 88
bacterial infections and mycoses (86) 86
ciprofloxacin (86) 86
tobramycin (83) 83
care and treatment (79) 79
drug therapy (79) 79
infection (77) 77
administration, inhalation (76) 76
anti-bacterial agents - metabolism (75) 75
monobactams - pharmacology (75) 75
cefotaxime - pharmacology (74) 74
klebsiella-pneumoniae (74) 74
medicine, general & internal (74) 74
antimicrobial agents (73) 73
klebsiella pneumoniae - drug effects (72) 72
aztreonam - analogs & derivatives (70) 70
bacterial infections - microbiology (70) 70
child, preschool (70) 70
inhaled aztreonam lysine (70) 70
safety (70) 70
efficacy (69) 69
cefepime (68) 68
drug synergism (68) 68
cystic fibrosis - drug therapy (66) 66
immunology (66) 66
injections, intravenous (65) 65
mice (65) 65
pathogens (65) 65
pseudomonas infections - microbiology (65) 65
strains (65) 65
infant (64) 64
lysine (64) 64
biological products industry (63) 63
cefotaxime (62) 62
hospitals (61) 61
airway pseudomonas (60) 60
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1878) 1878
Japanese (144) 144
Italian (57) 57
French (32) 32
Spanish (30) 30
Chinese (15) 15
German (11) 11
Portuguese (7) 7
Polish (6) 6
Russian (4) 4
Slovak (4) 4
Turkish (3) 3
Danish (1) 1
Korean (1) 1
Norwegian (1) 1
Romanian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 9/2010, Volume 51, Issue 6, pp. 641 - 650
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 11/2008, Volume 178, Issue 9, pp. 921 - 928
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 11/2010, Volume 65, Issue 4, pp. iv41 - iv51
Journal Article
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 03/2016, Volume 110, pp. 151 - 163
Journal Article
JOURNAL OF CYSTIC FIBROSIS, ISSN 1569-1993, 09/2018, Volume 17, Issue 5, pp. 560 - 561
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 11/2010, Volume 65, Issue 4, pp. iv53 - iv65
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2015, Volume 10, Issue 3, p. e0118454
textabstractBackground: Pseudomonas aeruginosa (Pa) infection is an important contributor to the progression of cystic fibrosis (CF) lung disease. The... 
INHALED AZTREONAM LYSINE | STANDARDIZATION | PSEUDOMONAS-AERUGINOSA INFECTION | PHARMACOKINETICS | SAFETY | DEPOSITION | MULTIDISCIPLINARY SCIENCES | COMPUTATIONAL FLUID-DYNAMICS | COMPUTED-TOMOGRAPHY | PK/PD TERMINOLOGY | REFERENCE RANGES | Lung - microbiology | Humans | Pseudomonas aeruginosa - growth & development | Cystic Fibrosis - pathology | Child, Preschool | Male | Tomography, X-Ray Computed | Aztreonam - pharmacology | Tidal Volume | Microbial Sensitivity Tests | Drug Dosage Calculations | Female | Retrospective Studies | Child | Lung - pathology | Respiratory Rate | Cystic Fibrosis - microbiology | Pseudomonas Infections - drug therapy | Administration, Inhalation | Pseudomonas Infections - complications | Treatment Outcome | Patient-Specific Modeling | Pseudomonas aeruginosa - drug effects | Cystic Fibrosis - complications | Pseudomonas Infections - microbiology | Aztreonam - pharmacokinetics | Lung - drug effects | Adolescent | Anti-Bacterial Agents - pharmacokinetics | Pseudomonas Infections - pathology | Anti-Bacterial Agents - pharmacology | Drug Monitoring | Cystic Fibrosis - drug therapy | Infection | Care and treatment | Usage | Antibiotics | Analysis | Cystic fibrosis | Models | Health aspects | Pediatrics | Particle size | Infections | Respiratory tract | Airway management | Computed tomography | Tomography | Pseudomonas aeruginosa | Mathematical models | Children | Drug dosages | Computer simulation | Computational fluid dynamics | Lung diseases | Abnormalities | Medical treatment | Patients | Inhalation | Asthma | Lobes | Hospitals | Lungs | Lysine | Computer applications | Fibrosis | Flow distribution | Aztreonam | Breathing | Mutation | Respiration | Three dimensional models
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 2015, Volume 70, Issue 9, pp. 2618 - 2626
Journal Article
Journal of Cystic Fibrosis, ISSN 1569-1993, 2015, Volume 14, pp. S91 - S91
Objectives To evaluate the experience of patients chronically colonised with Pseudomonas aeruginosa trialled on nebulised aztreonam lysine and their outcomes... 
Pulmonary/Respiratory | Lysine | Aztreonam
Journal Article
Journal Article